GMAB — Recent News Coverage

All news mentioning GMAB in ESEN's AI-graded feed

News stories with GMAB as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on GMAB. See /coverage/GMAB for the 30-day aggregate.

7 articles Updated: 2026-10-26 07:15 UTC Filter: Ticker: $GMAB
GURUFOCUS.COM · 2026-10-25 NEUTRAL NEUTRAL CORR0.25

Genmab (GMAB) and Incyte Launch Trial for KRAS G12D Colorectal Cancer Therapy Combo

$GMAB $INCY
◈ ESEN AI
Genmab and Incyte announced a clinical trial collaboration to evaluate a combination therapy targeting KRAS G12D mutations in colorectal cancer. This represents a standard pipeline advancement typical of large pharma R&…
MANILATIMES.NET · 2026-08-11 LOW NEUTRAL CORR0.15

Capital Increase in Genmab as a Result of Employee Warrant Exercise

$GMAB
◈ ESEN AI
Genmab announced a routine capital increase resulting from employee warrant exercises, a procedural disclosure reflecting equity compensation activity rather than operational or strategic developments. This type of anno…
SEEKINGALPHA.COM · 2026-08-07 NEUTRAL NEUTRAL CORR0.42

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

$GMAB
◈ ESEN AI
GMAB's Q2 2026 earnings call represents a routine periodic disclosure event typical for large-cap biopharmaceutical firms. The transcript publication itself carries minimal market-moving power absent concrete guidance r…
SEEKINGALPHA.COM · 2026-07-22 NEUTRAL NEUTRAL CORR0.42

Genmab: Multiple Late-Stage Readouts Ahead (NASDAQ:GMAB)

$GMAB $JNJ
◈ ESEN AI
Genmab (GMAB) faces a valuation disconnect between operational momentum and equity performance year-to-date. The biotech firm's commercial execution and pipeline advancement have demonstrated tangible progress, yet the …
FINANCE.YAHOO.COM · 2026-07-08 NEUTRAL BULLISH CORR0.42

Is Genmab A/S (GMAB) Stock Undervalued After Positive Epkinly DLBCL Trial Results?

$GMAB
◈ ESEN AI
Genmab A/S (GMAB) received analyst support following positive Epkinly diffuse large B-cell lymphoma (DLBCL) trial outcomes, with H.C. Wainwright lifting its price target to $40 from $38 while maintaining a Buy stance. T…
INSIDERMONKEY.COM · 2026-07-08 LOW BULLISH CORR0.42

10 Best Innovative Healthcare Stocks to Buy Now

$GMAB $CRNX
◈ ESEN AI
This article presents a curated list of innovative healthcare stocks positioned as attractive entry points following a prolonged period of sector underperformance. The healthcare sector has significantly trailed the bro…
MANILATIMES.NET · 2026-06-11 LOW NEUTRAL CORR0.15

Grant of Restricted Stock Units and Warrants to Employees in Genmab

$GMAB
◈ ESEN AI
Genmab announced a grant of restricted stock units (RSUs) and warrants to its employee base, a routine capital allocation mechanism designed to align workforce incentives with shareholder value creation. This type of eq…
EXPLORE OTHER FILTERS